Lancet Capital: Investing in early-stage biomedical innovations for value creation since 1998.
Location
Boston, MA, US
Founded
1998
Lancet Capital focuses on early-stage biomedical investments, particularly in innovative technologies within the biomedical field. As the first Small Business Investment Company (SBIC) affiliated with an academic medical center, Lancet aims to create value for investors and founders of portfolio companies. The firm typically invests in Series B rounds, supporting exceptional researchers, clinicians, and entrepreneurs.
Lancet Capital offers unique value-add services to its portfolio companies, including startup senior management, operations expertise, and business planning assistance. Founded in 1998 by William Golden and George Sing, the firm leverages its academic medical center affiliation to provide specialized support in commercializing biomedical innovations. Notable portfolio companies include Scion Pharmaceuticals, which has raised $17.5 million.
Lancet Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Total Portfolio Exits1
Top Investment Stages
Series B1 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
